Skip to main content
Fig. 2 | Diagnostic Pathology

Fig. 2

From: DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients

Fig. 2

Relationships between DDR gene mutations and TMB in NSCLC patients without EGFR or ALK gene alterations. (A-C) Relationship between DDR gene mutations and TMB in all NSCLC patients, LUAD patients and LUSC patients. (D-F) Relationship between mutations of different DDR pathways and TMB in all NSCLC patients, LUAD patients and LUSC patients. (G) Relationship between the number of DDR gene mutations and TMB in all NSCLC patients. LUAD: lung adenocarcinoma, LUSC: lung squamous cell carcinoma

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us